UA66807C2 - Композиція для подолання абстинентних симптомів та потягу до алкоголю в алкоголіків та запобігання зловживанням алкоголем у здорових осіб і спосіб її виготовлення (варіанти) - Google Patents

Композиція для подолання абстинентних симптомів та потягу до алкоголю в алкоголіків та запобігання зловживанням алкоголем у здорових осіб і спосіб її виготовлення (варіанти)

Info

Publication number
UA66807C2
UA66807C2 UA2000041867A UA00041867A UA66807C2 UA 66807 C2 UA66807 C2 UA 66807C2 UA 2000041867 A UA2000041867 A UA 2000041867A UA 00041867 A UA00041867 A UA 00041867A UA 66807 C2 UA66807 C2 UA 66807C2
Authority
UA
Ukraine
Prior art keywords
alcohol
alcoholics
craving
abuse
preventing
Prior art date
Application number
UA2000041867A
Other languages
English (en)
Russian (ru)
Inventor
Альдо Фассі
Клаудіо Кавазза
Original Assignee
Сігма-Тау Індустріе Фармачеутіке Ріуніте С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сігма-Тау Індустріе Фармачеутіке Ріуніте С.П.А. filed Critical Сігма-Тау Індустріе Фармачеутіке Ріуніте С.П.А.
Publication of UA66807C2 publication Critical patent/UA66807C2/uk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Addiction (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Описано склад, який містить L-карнітин, ацетил-L-карнітин, пропіонил-L-карнітин або їхні фармакологічно прийнятні солі і вживається як фармацевтичний засіб для подолання абстинентних симптомів та потягу до алкоголю в алкоголіків та як харчова добавка, здорова їжа, лікувальна їжа для запобігання зловживанням алкоголем у практично здорових осіб, особливо молодих.
UA2000041867A 1997-10-03 1998-09-18 Композиція для подолання абстинентних симптомів та потягу до алкоголю в алкоголіків та запобігання зловживанням алкоголем у здорових осіб і спосіб її виготовлення (варіанти) UA66807C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97RM000594A IT1295408B1 (it) 1997-10-03 1997-10-03 Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo
PCT/IT1998/000249 WO1999017623A1 (en) 1997-10-03 1998-09-18 Composition for suppressing withdrawal symptoms and craving for alcohol in alcoholics and preventing the abuse of alcohol in healthy subjects

Publications (1)

Publication Number Publication Date
UA66807C2 true UA66807C2 (uk) 2004-06-15

Family

ID=11405277

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2000041867A UA66807C2 (uk) 1997-10-03 1998-09-18 Композиція для подолання абстинентних симптомів та потягу до алкоголю в алкоголіків та запобігання зловживанням алкоголем у здорових осіб і спосіб її виготовлення (варіанти)

Country Status (28)

Country Link
US (1) US6255346B1 (uk)
EP (1) EP1022960B1 (uk)
JP (1) JP2001518484A (uk)
KR (2) KR100560097B1 (uk)
CN (1) CN1092939C (uk)
AT (1) ATE220860T1 (uk)
AU (1) AU730740B2 (uk)
BG (1) BG64363B1 (uk)
BR (1) BR9812604A (uk)
CA (1) CA2305598C (uk)
CZ (1) CZ291801B6 (uk)
DE (1) DE69806788T2 (uk)
DK (1) DK1022960T3 (uk)
EA (1) EA002177B1 (uk)
EE (1) EE04036B1 (uk)
ES (1) ES2180200T3 (uk)
HK (1) HK1028714A1 (uk)
HU (1) HUP0004336A3 (uk)
IS (1) IS2234B (uk)
IT (1) IT1295408B1 (uk)
MX (1) MXPA00003232A (uk)
NO (1) NO20001688L (uk)
NZ (1) NZ503663A (uk)
PL (1) PL189663B1 (uk)
PT (1) PT1022960E (uk)
SK (1) SK283384B6 (uk)
UA (1) UA66807C2 (uk)
WO (1) WO1999017623A1 (uk)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
IT1306179B1 (it) * 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
ITRM20020194A1 (it) * 2002-04-09 2003-10-09 Sigma Tau Healthscience Spa Composizione utile per aumentare la concentrazione e la motilita' degli spermatozoi e migliorarne la morfologia nell'uomo.
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
US7776913B2 (en) 2002-12-13 2010-08-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Carnitines for treating or preventing disorders caused by andropause
CN101766715B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766672B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766716B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766637B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766635B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766717B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN106176756A (zh) * 2015-04-30 2016-12-07 刘力 包含手性异构化合物的赖氨酸五维药物组合物及其用途
WO2021211540A1 (en) * 2020-04-14 2021-10-21 The Regents Of The University Of California Diagnosis and treatment of addiction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245869B (it) 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti Impiego di propionil l-carnitina per il recupero del tono muscolare in soggetti immobilizzati
DE19527281A1 (de) 1995-07-26 1997-01-30 Hans Guenter Berner Gmbh Nahrungsergänzungsmittel
EP0776604B1 (en) * 1995-12-01 2002-01-23 Unilever N.V. Microwavable crispy bread-rolls
EP0793962B1 (en) * 1996-03-04 1999-12-08 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Medicament containing a carnitine derivative for treating arteriosclerosis obliterans

Also Published As

Publication number Publication date
EP1022960B1 (en) 2002-07-24
CA2305598A1 (en) 1999-04-15
DK1022960T3 (da) 2002-11-04
KR20010030928A (ko) 2001-04-16
ITRM970594A1 (it) 1999-04-03
NO20001688L (no) 2000-06-02
EA200000377A1 (ru) 2000-10-30
KR100560097B1 (ko) 2006-03-13
HUP0004336A2 (hu) 2001-05-28
IS2234B (is) 2007-04-15
BG104286A (en) 2000-11-30
EE04036B1 (et) 2003-06-16
CN1092939C (zh) 2002-10-23
KR20050088499A (ko) 2005-09-06
SK283384B6 (sk) 2003-06-03
JP2001518484A (ja) 2001-10-16
SK4762000A3 (en) 2000-10-09
IT1295408B1 (it) 1999-05-12
WO1999017623A1 (en) 1999-04-15
EE200000235A (et) 2001-06-15
DE69806788D1 (de) 2002-08-29
EA002177B1 (ru) 2002-02-28
CA2305598C (en) 2007-11-20
NO20001688D0 (no) 2000-03-31
KR100530368B1 (ko) 2005-11-22
CZ291801B6 (cs) 2003-05-14
PL189663B1 (pl) 2005-09-30
CN1276704A (zh) 2000-12-13
BR9812604A (pt) 2000-08-01
AU730740B2 (en) 2001-03-15
NZ503663A (en) 2001-11-30
CZ20001207A3 (cs) 2000-11-15
PT1022960E (pt) 2002-12-31
EP1022960A1 (en) 2000-08-02
IS5416A (is) 2000-03-24
US6255346B1 (en) 2001-07-03
AU9366098A (en) 1999-04-27
BG64363B1 (bg) 2004-12-30
HK1028714A1 (en) 2001-03-02
HUP0004336A3 (en) 2001-07-30
MXPA00003232A (es) 2004-03-10
PL339621A1 (en) 2001-01-02
DE69806788T2 (de) 2003-04-03
ATE220860T1 (de) 2002-08-15
ES2180200T3 (es) 2003-02-01

Similar Documents

Publication Publication Date Title
Park et al. Concord grape juice supplementation reduces blood pressure in Korean hypertensive men: double‐blind, placebo controlled intervention trial
Fogarty et al. The role of diet in the aetiology of asthma.
UA66807C2 (uk) Композиція для подолання абстинентних симптомів та потягу до алкоголю в алкоголіків та запобігання зловживанням алкоголем у здорових осіб і спосіб її виготовлення (варіанти)
WO2002015719A3 (en) Nutritional composition
CA2294099A1 (en) Absorption of minerals
WO2000011968A8 (en) ANTIOXIDANT COMPOSITION COMPRISING ACETYL L-CARNITINE AND α-LIPOIC ACID
BR9815302A (pt) Método para diminuir a concentração de colesterol ldl e aumentar a concentração de colesterol hdl no sangue para reduzir o risco de aterosclerose e doença vascular
CA2271865A1 (en) Tablet composition
WO1999066913A3 (en) Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-l-carnitine and genistein
AU6391296A (en) Anti-intoxication composition
WO2001026666A3 (en) Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba
WO2001028526A3 (en) Gastroresistant tablets for alimentary, dietetic and therapeutic use
IL149360A0 (en) Method and compositions for administering taxanes orally to human patients
CA2395530A1 (en) Calcium formate for use as a phosphorus binder and a dietary supplement
CA2067243A1 (en) Compositions and methods for weight reduction
CA2391625A1 (en) Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl l-carnitine and chitosan
WO2001003683A3 (en) Cardioactive composition comprising l-carnitine and its derivatives and crataegus extracts
CA2325033A1 (en) Use of ribose to treat fibromyalgia
EP0778027A3 (de) Verwendung von Kieselerde zur Herstellung von Arzneimitteln
Ahuja et al. An unusual presentation of scurvy following head injury
CA2291974A1 (en) Composition comprising panax pseudo ginseng and eucommiae ulmoides
Thomas et al. Scurvy in a nonalcoholic person in the United States
Allen et al. Milk-like serum suggests markedly elevated triglycerides
Wang et al. A clinical study of penehyclidine hydrochloride as premedication of general anesthesia in children's oral surgery
Austin VITAMIN C REQUIREMENTS